Flow cytometry of human solid tumours: Clinical and research applications

Current Diagnostic Pathology

Volumn 8, Issue 4, 2002, Pages 249-267

  Corver, W E ^a   Cornelisse, C J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

DNA; Flow cytometry; Immunophenotyping; Neoplasms, genetics

Indexed keywords

DNA; MONOCLONAL ANTIBODY; PARAFFIN;

CELL CYCLE; CELL CYCLE S PHASE; CELL PERMEABILIZATION; CELL SURFACE; CELL SUSPENSION; CLINICAL RESEARCH; DNA CONTENT; FLOW CYTOMETRY; HEMATOPOIETIC CELL; HUMAN; HYDRODYNAMICS; LIGHT SCATTERING; LYMPHOID CELL; MEASUREMENT; NEOPLASM; PROTEIN EXPRESSION; REVIEW; SOLID TUMOR; STAINING;

EID: 0036697669     PISSN: 09686053     EISSN: None     Source Type: Journal    
DOI: 10.1054/cdip.2002.0125     Document Type: Review

References (77)

1. Caspersson T O. Microspectrography of Nucleotides and Proteins. Cell Growth and Cell Function. New York: W.W. Norton & Company, Inc., 1950; 61-77.
2. Moldavan A. Photo-electric technique for the counting of microscopical cells. Science 1934; 80: 188-189.
3. Reynolds O. An experimental investigation of the circumstances which determine whether the motion of water shall be direct of sinuous, and of the law of resistance in channels. Philos Trans R Soc London 1883; 174: 935-983.
4. Crosland-Taylor P J. A device for counting small particles suspended in a fluid through a tube. Nature 1953; 171: 37-38.
5. Kamentsky L A, Melamed M R, Derman H. Spectrophotometer: new instrument for ultrarapid cell analysis. Science 1965; 150: 630-631.
6. Salzman G C, Singham S B, Johnston R G, Bohren C F. Light scattering and cytometry. In: Melamed M R, Lindmo T, Mendelsohn M L (eds). Flow Cytometry and Sorting. New York: Wiley-Liss, Inc., 1990; 81-107.
7. Henderson L O, Marti G E, Gaigalas A, Hannon W H, Vogt R F Jr. Terminology and nomenclature for standardization in quantitative fluorescence cytometry. Cytometry 1998; 33: 97-105.
8. Hulett H R, Bonner W A, Barret J, Herzenberg L A. Cell sorting: automated separation of mammalian cells as a function of intracellular fluorescence. Science 1969; 166: 747-749.
9. Fulwyler M J. Electronic separation of biological cells by volume. Science 1965; 150: 910-911.
10. Vindelov L L, Christensen I J, Nissen N I. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 1983; 3: 323-327.
11. Hedley D W, Friedlander M L, Taylor I W, Rugg C A, Musgrove E A, Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem 1983; 31: 1333-1335.
12. Croonen A M, van der Valk P, Herman C J, Lindeman J. Cytology, Immunopathology and flow cytometry in the diagnosis of pleural and peritoneal effusions. Lab Invest 1988; 58: 725-732.
13. Hitchcock C L, Ensley J F. Technical considerations for dissociation of fresh and archival tumors. In: Bauer K D, Duque R E, Shankey T V (eds). Clinical Flow Cytometry. Baltimore: Williams & Wilkins, 1993; 93-110.
14. Engelholm S A, Spang Thomsen M, Brunner N, Nohr I, Vindelov L L. Disaggregation of human solid tumours by combined mechanical and enzymatic methods. Br J Cancer 1985; 51: 93-98.
15. Corver W E, Cornelisse C J, Hermans J, Fleuren G J. Limited loss of nine tumor-associated surface antigenic determinants after tryptic cell dissociation. Cytometry 1995; 19: 267-272.
16. Schmid I, Uittenbogaart C H, Giorgi J V. A gentle fixation and permeabilization method for combined cell surface and intracellular staining with improved precision in DNA quantification. Cytometry 1991; 12: 279-285.
17. Corver W E, Cornelisse C J, Fleuren G J. Simultaneous measurement of two cellular antigens and DNA using fluorescein-isothiocyanate, R-phycoerythrin, and propidium iodide on a standard FACScan. Cytometry 1994; 15: 117-128.
18. Camplejohn R S. The measurement of intracellular antigens and DNA by multiparameter flow cytometry. J Microsc 1994; 176: 1-7.
19. Toba K, Winton E F, Bray R A. Improved staining method for the simultaneous flow cytofluorometric analysis of DNA content, S-phase fraction, and surface phenotype using single laser instrumentation. Cytometry 1992; 13: 60-67.
20. Kohler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975; 256: 495-497.
21. Loken M R, Parks D R, Herzenberg L A. Two-color immunofluorescence using a fluorescence activated cell sorter. J Histo Cytochem 1977; 25: 899-907.
22. De Rosa S C, Herzenberg L A, Roederer M. 11-color, 13-parameter flow cytometry: identification of human naive T cells by phenotype, function, and T-cell receptor diversity. Nature Med 2001; 7: 245-248.
23. Rabinovitch P S, Torres R M, Engel D. Simultaneous cell cycle analysis and two-color surface immunofluorescence using 7-amino-actinomycin D and singel laser excitation. Applications to study of cell activation and the cell cycle of murine Ly-1 B cells. J Immunol 1986; 136: 2769-2777.
24. Van Hooijdonk C A E M, Glade C P, Van Erp P E J. TO-PRO-3 iodide: a novel HeNe laser-excitable DNA stain as an alternative for propidium iodide in multiparameter flow cytometry. Cytometry 1994; 17: 185-189.
25. Smith P J, Wiltshire M, Davies S, Patterson L H, Hoy T. A novel cell permeant and far red-fluorescing DNA probe, DRAQ5, for blood cell discrimination by flow cytometry. J Immunol Methods 1999; 229: 131-139.
26. Rabinovitch P S. Practical considerations for DNA content and cell cycle analysis. In: Bauer K D, Duque R E, Shankey T V (eds). Clinical Flow Cytometry. Baltimore: Williams & Wilkins, 1993; 117-142.
27. Devilee P, Cornelisse C J. Somatic genetic changes in human breast cancer. Biochim Biophys Acta 1994; 1198: 113-130.
28. Hiddemann W, Schumann J, Andreeff M, Barlogie B, Herman C J, Leif R C, Mayall B H, Murphy R F, Sandberg A A. Convention on nomenclature for DNA flow cytometry. Cytometry 1984; 5: 445-446.
29. Overton W R, Catalano E, McCoy J P, Jr. Method to make paraffin-embedded breast and lymph tissue mimic fresh tissue in DNA analysis. Cytometry 1996; 26: 166-171.
30. Leers M P G, Schutte B, Theunissen P H M H, Ramaekers F C S, Nap M. Heat pretreatment increases resolution in DNA flow cytometry of paraffin-embedded tumor tissue. Cytometry 1999; 35: 260-266.
31. Dittrich W, G6hde W. Impulsfluorometrie bei Einzelzellen in Suspensionen. Z Naturforsch 1969; 24b: 360-361.
32. Beerman H, Kluin P M, Hermans J, van de Velde C J, Cornelisse C J. Prognostic significance of DNA-ploidy in a series of 690 primary breast cancer patients. Int J Cancer 1990; 45: 34-39.
33. Toikkanen S, Joensuu H, Klemi P. The prognostic significance of nuclear DNA content in invasive breast cancer-a study with long-term follow-up. Br J Cancer 1989; 60: 693-700.
34. Dressler L G, Seamer L C, Owens M A, Clark G M, McGuire W L. DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens. Cancer 1988; 61: 420-427.
35. Ewers S B, Langstrom E, Baldetorp B, Killander D. Flowcytometric DNA analysis in primary breast carcinomas and clinicopathological correlations. Cytometry 1984; 5: 408-419.
36. Rodenburg C J, Cornelisse C J, Heintz P A, Hermans J, Fleuren G J. Tumor ploidy as a major prognostic factor in advanced ovarian cancer. Cancer 1987; 59: 317-323.
37. Hedley D W, Shankey T V, Wheeless L L. DNA cytometry consensus conference. Cytometry 1993; 14: 471.
38. Beerman H, Smit V T, Kluin P M, Bonsing B A, Hermans J, Cornelisse C J. Flow cytometric analysis of DNA stemline heterogeneity in primary and metastatic breast cancer. Cytometry 1991; 12: 147-154.
39. Schvimer M, Lash R H, Katzin W E. Intratumoral heterogeneity of DNA ploidy in breast carcinomas: a flow cytometric assessment of sampling techniques. Cytometry 1995; 22: 292-296.
40. Kaleli S, Kösebay D, Bese T, Demirkiran F, Öz U A, Arvas M, Aydinli K, Erkün E. A strong prognostic variable in endometrial carcinoma - Flow cytometric S-phase fraction. Cancer 1997; 79: 944-951.
41. Collin F, Chassevent A, Bonichon F, Bertrand G, Terrier P, Coindre J M. Flow cytometric DNA content analysis of 185 soft tissue neoplasms indicates that S-phase fraction is a prognostic factor for sarcomas. Cancer 1997; 79: 2371-2379,
42. Romero H, Schneider J, Burgos J, Bilbao J, Rodriguez-Escudero FJ. S-phase fraction identifies high-risk subgroups among DNA-diploid breast cancers. Breast Cancer Res Treat 1996; 38: 265-275.
43. Bagwell C B, Clark G M, Spyratos F, Chassevent A, Bendahl P O, Stal O, Killander D, Jourdan M L, Romain S, Hunsberger B, Baldetorp B. Optimizing flow cytometric DNA ploidy and S-phase fraction as independent prognostic markers for node-negative breast cancer specimens. Cytometry 2001; 46: 121-135.
44. Szöllosi J, Damjanovich S, Mátyus L. Application of fluorescence resonance energy transfer in the clinical laboratory: routine and research. Cytometry 1998; 34: 159-179.
45. Corver W E, Fleuren G J, Cornelisse C J. Improved single laser measurement of two cellular antigens and DNA-ploidy by the combined use of propidium iodide and TO-PRO-3 iodide. Cytometry 1997; 28: 329-336.
46. Corver W E, Fleuren G J, Cornelisse C J. Software compensation improves the analysis of heterogeneous tumor samples stained for multiparameter DNA flow cytometry. J Immunol Methods 2002; 260: 97-107.
47. Ramaekers F C S, Beck H, Vooijs G P, Herman C J. Flowcytometric analysis of mixed cell populations using intermediate filament antibodies. Exp Cell Res 1984; 153: 249-253.
48. Oud P S, Henderik J B J, Beck H L M, Veldhuizen J A M, Vooijs G P, Herman C J, Ramaekers F C S. Flow cytometric analysis and sorting of human endometrial cells after immunocytochemical labeling for cytokeratin using a monoclonal antibody. Cytometry 1985; 6: 159-164.
49. Van der Linden J C, Herman C J, Boenders J G C, Van de Sandt M M, Lindeman J. Flow cytometric DNA content of fresh tumor specimens using keratin-antibody as second stain for two-parameter analysis. Cytometry 1992; 13: 163-168.
50. Visscher D W, Zarbo R J, Jacobsen G, Kambouris A, Talpos G, Sakr W, Crissman J D. Multiparameter deoxyribonucleic acid and cell cycle analysis of breast carcinomas by flow cytometry. Lab Invest 1990; 62: 370-378.
51. I. Zarbo R J, Visscher D, Crissman J D. Two-color multiparametric method for flow cytometric DNA analysis of carcinomas using staining for cytokeratin and leukocyte-common antigen. Anal Quant Cytol Histol 1989; 11: 391-402.
52. Corver W E, Bonsing B A, Abeln E C A, Vlak-Theil P M, Cornelisse C J, Fleuren G J. One tube triple staining method for the flow cytometric analysis of DNA ploidy and phenotypic heterogeneity of human solid tumors using single laser excitation. Cytometry 1996; 25: 358-366.
53. Corver W E, Koopman L A, Mulder A, Cornelisse C J, Fleuren G J. Distinction between HLA class I positive and negative cervical tumor subpopulations by multiparameter DNA flow cytometry. Cytometry 2000; 41: 73-80.
54. Frei J V, Martinez V J. DNA flow cytometry of fresh and paraffin-embedded tissue using cytokeratin staining. Mod Pathol 1993; 6: 599-605.
55. Nylander K, Stenling R, Gustafsson H, Roos G. Application of dual parameter analysis in flow cytometric DNA measurements of paraffin-embedded samples. J Oral Pathol Med 1994; 23: 190-192.
56. Glogovac J K, Porter P L, Banker D E, Rabinovitch P S. Cytokeratin labeling of breast cancer cells extracted from paraffin-embedded tissue for bivariate flow cytometric analysis. Cytometry 1996; 24: 260-267.
57. Steck K, McDonnell T, Sneige N, El-Naggar A. Flow cytometric analysis of apoptosis and BCL-2 in primary breast carcinomas: clinical and biological implications. Cytometry 1996; 24: 116-122.
58. Braylan R C, Benson N A, Nourse V, Kruth H S. Correlated analysis of cellular DNA, membrane antigens and light scatter of human lymphoid cells. Cytometry 1982; 2: 337-343.
59. Valet G, Russmann L, Wirsching R. Automated flow-cytometric identification of colo-rectal tumour cells by simultaneous DNA, CEA-antibody and cell volume measurements. J Clin Chem Clin Biochem 1984; 22: 935-942.
60. Fowler W C, Jr, Maddock M B, Moore D H, Haskill S. Significance of multiparameter flow cytometric analysis of ovarian cancer. Am J Obstet Gynecol 1988; 158: 838-845.
61. Van Dam P A, Watson J V, Lowe D G, Chard T, Shepherd J H. Comparative evaluation of fresh, fixed, and cryopreserved solid tumor cells for reliable flow cytometry of DNA and tumor associated antigen. Cytometry 1992; 13: 722-729.
62. Brotherick I, Shenton B K, Cowan W K, Angus B, Horne C H W, Higgs M J, Lennard T W J. The relationship between flow-cytometric and immunohistochemically detected c-erbB-2 expression, grade and DNA ploidy in breast cancer. Cancer Immunol Immunother 1995; 41: 137-145.
63. Diederichsen A C, Ostenhom A C, Kronborg O, Fenger C, Jensenius J C, Zeuthen J, Christensen P B, Kristensen T. Flow cytometric investigation of immune-response-related surface molecules on human colorectal cancers. Int J Cancer 1998; 79: 283-287.
64. Watson J V. Oncogenes, Cancer and analytical cytology. Cytometry 1986; 7: 400-410.
65. Watson J V, Stewart J, Cox H, Sikora K, Evan G I. Flow cytometric quantitation of the c-myc oncoprotein in archival neoplastic biopsies of the colon. Mol Cell Probes 1987; 1: 151-157.
66. Morkve O, Halvorsen O J, Stangeland L, Gulsvik A, Laerum O D. Quantitation of biological tumor markers (p53, c-myc, Ki-67 and DNA ploidy) by multiparameter flow cytometry in non-small-cell lung cancer. Int J Cancer 1992; 52: 851-855.
67. Remvikos Y, VuHai M T, Lainė-Bidron C, Jollivet A, Magdelénat H. Progesterone receptor detection and quantification in breast tumor by bivariate immunofluorescence/DNA flow cytometry. Cytometry 1991; 10: 157-166.
68. Tominaga O, Hammel P, Hamelin R, Nagawa H, Muto T, Remvikos Y. Quantification and characterization of total cellular p53 protein in colorectal cancer. Cytometry 1998; 31: 60-66.
69. Shackney S E, Smith C A, Pollice A A, Janocko L E, Singh S G, Groft D W, Brown K A, Hartsock R J. Preferred genetic evolutionary sequences in human breast cancer: a case study. Cytometry 1995; 21: 6-13.
70. Stomper P C, Budnick R M, Stewart C C. Use of specimen mammography-guided FNA (fine-needle aspirates) for flow cytometric multiple marker analysis and immunophenotyping in breast cancer. Cytometry 2000; 42: 165-173.
71. Corver W E, Koopman L A, Van der Aa J, Regensburg M, Fleuren G J, Cornelisse C J. Four-color multiparameter DNA flow cytometric method to study phenotypic intratumor heterogeneity in cervical cancer. Cytometry 2000; 39: 96-107.
72. Koopman L A, Corver W E, Van der Slik A R, Giphart M J, Fleuren G J. Multiple genetic alterations cause frequent and heterogeneous human histocompatibility leukocyte antigen class I loss in cervical cancer. J Exp Med 2000; 191: 961-975.
73. Abeln E C A, Corver W E, Kuipers-Dijkshoorn N J, Fleuren G J, Cornelisse C J. Molecular genetic analysis of flow-sorted ovarian tumour cells: improved detection of loss of heterozygosity. Br J Cancer 1994; 70: 255-262.
74. Bonsing B A, Corver W E, Fleuren G J, Cleton-Jansen A M, Devilee P, Cornelisse C J. Allelotype analysis of flow-sorted breast cancer cells demonstates genetically related diploid and aneuploid subpopulations in primary tumors and lymph node metastasis. Genes Chromosomes Cancer 2000; 28: 173-183.
75. Li B D L, Harlow S P, Budnick R M, Sheedy D L, Stewart C C. Detection of HER-2/neu oncogene amplification in flow cytometry-sorted breast ductal cells by competitive polymerase chain reaction. Cancer 1994; 73: 2771-2778.
76. Barrett M T, Sanchez C A, Prevo L J, Wong D J, Galipeau P C, Paulson T G, Rabinovitch P S, Reid B J. Evolution of neoplastic cell lineages in Barrett oesophagus. Nat Genet 1999; 22: 106-109.
77. Barrett M T, Glogovac J, Porter P, Reid B J, Rabinovitch P S. High yields of RNA and DNA suitable for array analysis from cell sorter purified epithelial cell and tissue populations. Abstract. Nat Genet 1999; 23, 32-33.